Salem Investment Counselors Inc Charles River Laboratories International, Inc. Transaction History
Salem Investment Counselors Inc
- $2.81 Billion
- Q1 2025
A detailed history of Salem Investment Counselors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 145 shares of CRL stock, worth $20,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145
Previous 145
-0.0%
Holding current value
$20,104
Previous $26,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
650Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$847 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$705 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$594 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$332 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$270 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.05B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...